Sterling Investment Counsel’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
Sterling Investment Counsel's AMGN Position: Q2 2026 in Review
Sterling Investment Counsel reduced its Amgen (AMGN) stake by 14% in Q2 2026, selling an estimated $50.3K and leaving 921 shares worth $334K. The position accounts for 0.08% of the portfolio, ranked #141.
Sterling Investment Counsel first reported a position in AMGN in Q4 2021 and has held it in 17 quarters since. The position peaked at $680K in Q3 2024. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Sterling Investment Counsel held 921 shares of Amgen worth $334K as of Q2 2026.
- Sterling Investment Counsel sold 147 Amgen shares in Q2 2026, an estimated $50.3K.
- Amgen made up 0.08% of Sterling Investment Counsel's portfolio in Q2 2026, its #141 holding.
- Sterling Investment Counsel first reported a position in Amgen in Q4 2021 and has held it in 17 quarters since.
- Sterling Investment Counsel's Amgen position peaked at $680K in Q3 2024.
- 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Sterling Investment Counsel's 13F filing for Q2 2026, filed 20 Jul 2026.